BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33001299)

  • 1. ASO Author Reflections: Clinical Correlates of Moderate-Penetrance Genes in Breast Cancer.
    Bergstrom CP; Pence C; Syed S
    Ann Surg Oncol; 2021 Jun; 28(6):3394-3395. PubMed ID: 33001299
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Using Tumor Genomics to Predict Axillary Response to Chemotherapy in Breast Cancer.
    James TA; Fan B
    Ann Surg Oncol; 2021 Mar; 28(3):1326-1327. PubMed ID: 33417122
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Contralateral Prophylactic Mastectomy in Breast Cancer Patients with CHEK2 Gene Mutations.
    Nizic-Kos T; Besic N
    Ann Surg Oncol; 2021 May; 28(5):2571-2572. PubMed ID: 33073339
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Using the Cancer Genome Atlas to Investigate the Role of Genetics in Breast Cancer Disparities.
    Johnson JA; Newman LA
    Ann Surg Oncol; 2024 Feb; 31(2):999-1000. PubMed ID: 37968410
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients.
    Shelton C; Nielsen SM
    Ann Surg Oncol; 2024 Feb; 31(2):1007. PubMed ID: 37996642
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline Testing.
    Murphy BL; Arun BK
    Ann Surg Oncol; 2023 May; 30(5):2914-2915. PubMed ID: 36705815
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients.
    Bokkers K; Ausems MGEM
    Ann Surg Oncol; 2023 Jun; 30(6):3259-3260. PubMed ID: 36826617
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: A Green Light for Genetic Testing in All Patients with Breast Cancer.
    Culver JO
    Ann Surg Oncol; 2023 Feb; 30(2):1026-1027. PubMed ID: 36241948
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes.
    Weiss A; Garber JE; King T
    JAMA Surg; 2018 Dec; 153(12):1145-1146. PubMed ID: 30167656
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Inheritance of Adrenal Permissive HSD3B1 Genotype Negatively Impacts Outcomes in Hormone Receptor-Positive Postmenopausal Breast Cancer.
    Flanagan MR; Sharifi N; Gadi VK
    Ann Surg Oncol; 2022 Oct; 29(11):7202-7203. PubMed ID: 35819571
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors that impact risk management decisions among women with pathogenic variants in moderate penetrance genes associated with hereditary breast cancer.
    Napoli M; Lewis J; Hopper J; Widmeyer K
    J Genet Couns; 2020 Dec; 29(6):960-970. PubMed ID: 32012395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Age Is an Important Determinant of Concordance Between 21-Gene Recurrence Scores in Multiple Ipsilateral Breast Carcinomas.
    Pawloski KR; Tadros AB; El-Tamer M
    Ann Surg Oncol; 2021 Aug; 28(8):4263-4264. PubMed ID: 33415560
    [No Abstract]   [Full Text] [Related]  

  • 13. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes.
    Hunter DJ; Riboli E; Haiman CA; Albanes D; Altshuler D; Chanock SJ; Haynes RB; Henderson BE; Kaaks R; Stram DO; Thomas G; Thun MJ; Blanché H; Buring JE; Burtt NP; Calle EE; Cann H; Canzian F; Chen YC; Colditz GA; Cox DG; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Hankinson SE; Hirschhorn JN; Hoover RN; Key T; Kolonel LN; Kraft P; Le Marchand L; Liu S; Ma J; Melnick S; Pharaoh P; Pike MC; Rodriguez C; Setiawan VW; Stampfer MJ; Trapido E; Travis R; Virtamo J; Wacholder S; Willett WC;
    Nat Rev Cancer; 2005 Dec; 5(12):977-85. PubMed ID: 16341085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASO Author Reflections: Clinical Importance of Histologic Subtype for Metaplastic Breast Cancer.
    Tadros AB; Plitas G
    Ann Surg Oncol; 2021 Aug; 28(8):4254-4255. PubMed ID: 33403524
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Breast Contour-Preserving Procedures as a Means to Address the Esthetic Outcome of Breast Cancer Treatment.
    van Bommel A; van Dalen T
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):721-722. PubMed ID: 31485822
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Less is Better in Breast Cancer Surgery.
    Acea-Nebril B; GarcĂ­a-Novoa A
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):778-779. PubMed ID: 31605321
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer gene discovery.
    Polyak K
    Expert Rev Mol Med; 2002 Aug; 4(18):1-18. PubMed ID: 14987381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer-Related Low Penetrance Genes.
    Kang D; Choi JY
    Adv Exp Med Biol; 2021; 1187():419-434. PubMed ID: 33983592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Impact of Radiotherapy for Breast Cancer is Changing in the Modern Era.
    Miyashita M; Niikura N; Tokuda Y
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):780-781. PubMed ID: 31605336
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: The BREAST-Q BCT Module and Its Use in Clinical Practice.
    Stolpner I; Heil J; Hennigs A
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):788-789. PubMed ID: 31617118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.